FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease.

Chen R, Morris BJ, Donlon TA, Masaki KH, Willcox DC, Davy PMC, Allsopp RC, Willcox BJ. FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease. Aging (Albany NY). 2020 12 01; 12(23):23509-23524.

View in: PubMed

subject areas

Age Factors
Aged
Aged, 80 and over
Case-Control Studies
Coronary Disease
Diabetes Mellitus, Type 2
Genetic Association Studies
Genetic Predisposition to Disease
Hawaii
Humans
Hypertension
Japan
Longevity
Longitudinal Studies
Male
Phenotype
Polymorphism, Single Nucleotide
Prevalence
Risk Assessment
Sex Factors

authors with profiles

Richard Allsopp, PhD
Kamal Masaki MD PhD
Philip Davy, PhD
Bradley Willcox, MD MSc

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support